期刊文献+

乳腺发育和乳腺疾病中细胞凋亡基因的表达规律及其调控 被引量:3

The laws and Regulation of Apoptosis in Mammogenesis and Mammary Disease
下载PDF
导出
摘要 阐述了细胞凋亡的形态变化、细胞凋亡的途径以及细胞凋亡在乳腺发育过程和乳腺疾病的发生及防御中的表达。研究乳腺细胞凋亡的基本规律和基因调控过程,能更好的了解乳腺发育过程,并用相关基因作为诊断乳腺疾病的指标。 This article mainly expounds morphologie changes, pathways and expression of apoptosis in mammogenesis and mammary diseases. More apoptotic fundamental laws and gene regulation of the roam- mary epithelial cells being studied, will be helpful to comprehend mammary growth well, helpful to use gene as an indicator to diagnose mammary disease.
出处 《家畜生态学报》 2008年第5期9-12,共4页 Journal of Domestic Animal Ecology
关键词 细胞凋亡 凋亡途径 乳腺发育 乳腺疾病 Apoptosis apoptotic pathway mammogenesis mammary disease
  • 相关文献

参考文献19

  • 1Stefanon B, Colitti M, Gabai G,et al. Mammary apoptosis and lactation persistency in dairy animals[J].J dairy research, 2002,69(1) :37-52.
  • 2Green K A, Streuli C H. Apoptosis regulation in the mammary gland[J]. Cell molecular life Science, 2004, 61 (15):1867- 1883.
  • 3Ann N Y . The morphology of apoptosis[J]. Academic Science, 2003,1995 : 94-108.
  • 4Bryony S, Wiseman Zena Werb. Stromal Effects on Mammary Gland Development and Breast Cancer[J]. Science, 2002,296 (5570) : 1046-1049.
  • 5Arnaud A,Mailleux, Michael Overholtzer, et al. BIM regulates apoptosis during mammary ductal morphogenesis and Its absence reveals alternative cell death mechanisms[J]. Development cell,2007, 12(2):221-234.
  • 6Quaglino A, Schere-Levy CP, Romorini L, et al. Mouse mammary tumors display LIF signaling dependent Stat3 activation[J]. Breast Cancer Res,2007,9(5):69.
  • 7Garbe JC, Hoist CR, Bassett E, et al . Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis[J].Cell Cycle, 2007,6 (15):1927-1936.
  • 8Stallings-Mann M, Radisky D. Matrix metalloproteinase-induced malignancy in mammary epithelial cells[J]. Cells Tissues Organs, 2007,185 (1-3):104-110.
  • 9Yang D, Stewart TJ, Smith KK, et al . Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression[J].Int J Cancer,2007,4.
  • 10Garcia-Tuon I, Ricote M, Ruiz A,et al. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study[J]. Breast Cancer Res, 2004,6 ( 1 ) : 1-7.

二级参考文献16

  • 1王仲,鲁向明.乳腺癌与Fas系统[J].世界肿瘤杂志,2004,3(3):291-293. 被引量:1
  • 2于志勇,左文述,魏玲,薛兴奎,卓培英,宋现让,刘玉谭,刘岩松,周正波,邵志敏.阿霉素对不同乳腺癌细胞株的抑制及凋亡调控作用[J].中华医学杂志,2005,85(1):19-22. 被引量:10
  • 3Vanchieri C. Studies shedding light on vitamin D and cancer [J]. J Natl Cancer Inst, 2004,96(10) :735 -736.
  • 4Christensen GL, Jepsen JS, Fog CK, et al. Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EBI089 and evaluation of predictive markers for vitamin D treatment [J]. Breast Cancer Res Treat, 2004,85( 1 ) :53-63.
  • 5Li F, Ling X, Huang H, et al. Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines [ J ]. Oncogene, 2005,24 ( 8 ) :1385 - 1395.
  • 6Rossi AM, Capiati DA, Picotto G, et al. MAPK inhibition by 1 alpha,25 (OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src [ J]. J Steroid Biochem Mol Biol,2004,89-90(1-5) :287 -290.
  • 7Capiati DA, Rossi AM, Picotto G, et al. Inhibition of serum-stimulated mitogen activated protein kinase by I alpha, 25 (OH)2-vitamin D3 in MCF-7 breast cancer cells [ J ]. J Cell Biochem, 2004,93(2) :384 - 397.
  • 8Conde 1, Paniagua R, Fraile B, et al. Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: Identification of potential heterodimeric receptors [J]. Int J Oncol, 2004,25 (4) :1183 - 1191.
  • 9Goillot E, Raingeaud J, Banger A, et al. Mitogen-activated protein kinase-mediated Fas apoptosis signaling pathway [J]. Proc Natl Acad Sci USA, 1997,94(7):3302 - 3307.
  • 10Botti C, Buglioni S, Benevolo M,et al. Altered expression of FAS system is related to adverse clinical outcome in stage Ⅰ-Ⅱ breast cancer patients treated with adjuvant anthracycline-based chemotherapy[J] .CAin Cancer Res,2004, 10(4):1360- 1365.

共引文献6

同被引文献27

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部